There was a non-significant difference in the correlation between IFRD1 and ESR1 gene expression levels in breast cancer patients; additionally, those patients had significantly negative ER statuses, corroborating the lack of a relation between its action and the hormonal status of the patient. This evidence concerns the gene IFRD1 and breast carcinoma.